World AIDS Day is observed annually on December 1 to raise global awareness on HIV/AIDS, honour those who died from HIV-related illnesses, and reaffirm support for People Living with HIV (PLHIV).
About World AIDS Day
- Origin: It was the first-ever global health day established by the World Health Organization (WHO) in 1988.
- Date: Observed on 1st December
- Purpose: To promote public awareness on HIV prevention, treatment, and stigma reduction.
- The Red Ribbon is the universal symbol of awareness and support for people living with HIV/AIDS.
- 2025 Theme: “Take the Rights Path: My Health, My Right!”
- Objective of the Theme: The theme highlights the need to transform HIV services to become resilient, equitable, and community-driven, especially in the face of pandemics, conflicts, and inequalities that disrupt access to care.
- Nodal Ministry: Led by the National AIDS Control Organization (NACO) under the Ministry of Health & Family Welfare.
|
What is HIV/AIDS?
- Definition: HIV (Human Immunodeficiency Virus) is a virus that weakens the immune system by attacking CD4 cells, which are essential for defending the body against infections.
- Over time, HIV weakens immunity, making the person vulnerable to opportunistic infections.
- Progression to AIDS:
- AIDS (Acquired Immunodeficiency Syndrome) is the most advanced stage of HIV infection.
- It occurs when the immune system becomes severely damaged and CD4 count falls below 200 cells/mm³, or when the person develops serious opportunistic diseases (e.g., TB, cancers).
- Transmission of HIV:
- Sexual Transmission: HIV spreads through unprotected sexual contact with an infected individual.
- Transmission Through Needles: Sharing contaminated needles or syringes is a major source of HIV transmission.
- Mother-to-Child Transmission: The virus can pass from mother to child during pregnancy, childbirth, or breastfeeding.
- Blood Transfusion Risk: Transfusion of infected blood can spread HIV, although this has become extremely rare due to strict screening systems.
- HIV does NOT spread through casual contact like touching, hugging, food sharing, mosquito bites, or air.
- Treatment:
- Although there is no cure for HIV, Antiretroviral Therapy (ART) effectively controls the virus.
- ART must be taken daily and lifelong to maintain immune function and prevent progression to AIDS.
India’s HIV/AIDS Response and Historical Journey
- Early National Efforts (1985–1991): India’s initial phase focused on identifying HIV cases, ensuring safe blood transfusions, and launching targeted public awareness initiatives.
- Institutional Framework: Establishment of the National AIDS Control Organisation (NACO) and National AIDS Control Programme (NACP) in 1992 under the Ministry of Health created a coordinated, multisectoral national response.
- Over time, the response shifted from centralised control toward district-level engagement, NGO participation, and stronger PLHIV networks.
National AIDS Control Programme (NACP)
- Evolution: NACP has progressed through five phases, moving from basic awareness efforts to a comprehensive prevention–testing–treatment model.
NACP I (1992–1999)
- This phase marked India’s first nationwide HIV/AIDS prevention strategy.
- The main aim was to slow HIV transmission and reduce resulting morbidity, mortality, and socio-economic impact.
NACP II (1999–2006)
- The programme expanded its focus and strengthened earlier interventions.
- Focused on two key objectives:
- Reduce the spread of HIV in India.
- Strengthen long-term national capacity to respond to HIV/AIDS.
NACP III (2007–2012)
- Goal: Aimed at halting and reversing the HIV epidemic over a five-year period through expanded prevention, care, and treatment strategies.
- Key Addition: District AIDS Prevention and Control Units (DAPCUs) were established to strengthen district-level monitoring and address stigma and discrimination.
NACP IV (2012–2017)
- Goal: The goal was to accelerate epidemic reversal and deliver an integrated HIV response.
- Major Objectives:
-
- Achieve a 50% reduction in new infections (compared to 2007).
- Ensure universal access to care, support, and treatment for all PLHIV.
Extension (2017–2021): Extended to advance the goal of Ending AIDS by 2030.
Key Initiatives During Extension are
- HIV/AIDS Act 2017: The HIV/AIDS (Prevention and Control) Act, 2017 prohibited discrimination, protected confidentiality, and mandated informed consent for testing and treatment.
- Mission Sampark: This mission worked to trace and re-engage PLHIV who had discontinued ART.
Test and Treat Policy: ART began for all diagnosed individuals, regardless of their CD4 count.
- Viral Load Monitoring: Routine universal viral load testing was implemented to improve treatment adherence and outcomes.
NACP V (2021–2026)
- Type: Implemented as a Central Sector Scheme with a financial outlay of ₹15,471.94 crore.
- Key Focus: Aims to consolidate earlier achievements while tackling emerging challenges in prevention, testing, and treatment.
- Alignment with SDGs: This Phase supports SDG 3.3, targeting the end of HIV/AIDS as a public health threat by 2030, with a focus on community-led interventions.
Government Steps for HIV/AIDS Awareness
- Mass Media Campaigns: NACO conducts extensive multimedia and digital campaigns to reach broader and younger populations.
- Outdoor Awareness Initiatives: Outreach is expanded using hoardings, bus panels, IEC vans, kiosks, and folk performances.
- Community Mobilisation: Training of SHGs, Anganwadi Workers, ASHAs, and Panchayati Raj representatives helps strengthen awareness at the grassroots level.
- Targeted Intervention Projects: As of October 2025, there are 1,587 Targeted Intervention (TI) projects ensuring prevention, testing, and treatment services for HRGs.
- Anti-Stigma Campaigns: Nationwide thematic campaigns work to reduce stigma and promote inclusion of PLHIV in workplaces and institutions.
- Legal Protection Mechanisms: Ombudsmen have been appointed in 34 States/UTs under the HIV and AIDS Act, 2017 to address discrimination complaints and safeguard PLHIV rights.
HIV/AIDS Cases in India
- Decline in HIV Prevalence:
- India’s HIV prevalence has fallen from 0.33% in 2010 to 0.20% in 2024.
- At 0.20%, India’s prevalence remains far below the global average of 0.7%, demonstrating the country’s success in maintaining a low-level epidemic and outperforming global trends.
- New HIV Infections: New HIV infections have decreased sharply from 1.25 lakh cases in 2010 to 64,500 cases in 2024, marking a 49% reduction when compared to the 2010 baseline used under NACP.
- This decline exceeds the global reduction rate of 40% during the same period.
- Decline in AIDS-Related Deaths: It has dropped by 81.40%, falling from 1.73 lakh deaths in 2010 to 32,200 deaths in 2024.
|